BioMark Diagnostics Inc.
BUX
Rangering i aksjer
#26616
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Aksjekurs
$0.34495034
Markedsverdi
$36.73M
Endring (1 dag)
0.00%
Endring (1 år)
41.11%
Land
CA
Handel BioMark Diagnostics Inc. (BUX)
Kategori
Healthcare
Historikk for aksjesplitt for BioMark Diagnostics Inc. (BUX)
Aksjen BioMark Diagnostics Inc. (symbol: BUX) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én BUX-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 BUX-aksjer.
Den nyeste splittelsen skjedde Oct 20, 2026.
Én BUX-aksje kjøpt før Oct 20, 2026 tilsvarer i dag 0 BUX-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
